4-[1-(3-fluoro-benzyl)-1H-indol-4-yl]-piperazine-1-carboxylic acid tert-butyl ester | 920285-05-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 4-[1-(3-fluoro-benzyl)-1H-indol-4-yl]-piperazine-1-carboxylic acid tert-butyl ester
• 英文别名: Tert-butyl 4-[1-[(3-fluorophenyl)methyl]indol-4-yl]piperazine-1-carboxylate
• CAS: 920285-05-8
• 化学式: C₂₄H₂₈FN₃O₂
• 分子量: 409.504
• InChiKey: KKOSPDGJGJYMHU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  30
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  37.7
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-[1-(3-fluoro-benzyl)-1H-indol-4-yl]-piperazine-1-carboxylic acid tert-butyl ester 在 N-溴代丁二酰亚胺(NBS) 作用下， 以 二氯甲烷 为溶剂， 反应 0.5h， 生成 4-[3-bromo-1-(3-fluoro-benzyl)-1H-indol-4-yl]-piperazine-1-carboxylic acid tert-butyl ester
  参考文献：
  名称：

  Benzimidazolone and dihydroindolone derivatives and uses thereof

  摘要：

  式I的化合物： 或其药学上可接受的盐，其中m、n、X、Ar、R1、R2、R3、R4和R5如本文所定义。还提供了制备方法、包含化合物I的组合物以及使用式I化合物的方法。

  公开号：

  US20070015744A1
• 作为产物：
  描述：

  4-(1H-4-吲哚)-哌嗪-1-羧酸叔丁酯 、 3-氟溴苄 在 18-冠醚-6 、 potassium tert-butylate 作用下， 以 四氢呋喃 为溶剂， 反应 0.33h， 生成 4-[1-(3-fluoro-benzyl)-1H-indol-4-yl]-piperazine-1-carboxylic acid tert-butyl ester
  参考文献：
  名称：

  Effects of chronic mild stress on rats selectively bred for behavior related to bipolar disorder and depression

  摘要：

  To test the possibility that chronic mild stress (CMS) might be unreliable in producing its often-intended outcome (i.e., decreased preference for sucrose, hypothesized to represent depression-relevant anhedonia) because it is typically applied to "normal" rats, a CMS procedure was applied to rats that may possess genetic susceptibility to affective disorders, having had been selectively-bred to show behavior indicative of such disorders. These rat lines were: Hyperactive (HYPER) rats, which show characteristics of bipolar disorder, Swim-test Susceptible (SUS) and Swim-test Resistant (RES) rats, being susceptible or resistant to effects of stress in the swim test, Swim High-active (SwHi) and Swim Low-active (SwLo) rats, which innately show high or low activity in the swim test These selectively-bred lines were compared to normal, non-selectively bred (NS) rats. During CMS, HYPER rats, both females and males, as well as RES and SwHi rats, showed reduced consumption of a palatable 2% sucrose solution, and reduced preference for sucrose (vs. water) in comparison to non-stressed rats (no CMS) of the same lines. In contrast, CMS produced no decrease in sucrose consumption or in preference for sucrose in normal NS rats, and actually a caused a slight increase in sucrose consumption and preference in male NS rats. Other measures that indicate depression - food intake and motor activity in the home cage - were also assessed. SwLo and SwHi showed greater sensitivity to having their home-cage ambulatory activity reduced by CMS than did NS rats, but no other such differences relative to NS rats were seen for these other measures; thus, changes in sucrose intake or preference could not be explained by a change in caloric intake. These results suggest that the genetic attributes of animals can influence the outcome of CMS, and that the application of CMS to normal, non-selected rats may account, at least in part, for the unreliability of CMS in decreasing consumption of palatable substances and decreasing preference for such substances. (C) 2013 Published by Elsevier Inc.

  DOI：

  10.1016/j.physbeh.2013.05.042

文献信息

• BENZIMIDAZOLE DERIVATIVES AS 5-HT6,5-HT24
  申请人：F. Hoffmann-La Roche AG

  公开号：EP1904483A1

  公开（公告）日：2008-04-02
• US7582760B2
  申请人：——

  公开号：US7582760B2

  公开（公告）日：2009-09-01
• [EN] BENZIMIDAZOLE DERIVATIVES AS 5-HT6,5-HT24<br/>[FR] DERIVES DE BENZIMIDAZOLE TELS QUE 5-HT6, 5-HT24
  申请人：HOFFMANN LA ROCHE

  公开号：WO2007006677A1

  公开（公告）日：2007-01-18

  [EN] Compounds of the formula I: or pharmaceutically acceptable salts thereof wherein m, n, X, Ar, R¹, R², R³, R⁴ and R⁵ are as defined herein. Also provided are methods for preparing, compositions comprising, and methods for using compounds of formula I.
  [FR] L'invention concerne des composés représentés par la formule I, ou des sels pharmaceutiquement acceptables de ces derniers. Dans ladite formule, m, n, X, Ar, R¹, R², R³, R⁴et R⁵ sont tels que définis dans la description. L'invention concerne également des procédés de préparation, des compositions comprenant et des méthodes d'utilisation des composés représentés par la formule I.
• Benzimidazolone and dihydroindolone derivatives and uses thereof
  申请人：Owens Timothy

  公开号：US20070015744A1

  公开（公告）日：2007-01-18

  Compounds of the formula I: or pharmaceutically acceptable salts thereof wherein m, n, X, Ar, R 1 , R 2 , R 3 , R 4 and R 5 are as defined herein. Also provided are methods for preparing, compositions comprising, and methods for using compounds of formula I.

  式I的化合物： 或其药学上可接受的盐，其中m、n、X、Ar、R1、R2、R3、R4和R5如本文所定义。还提供了制备方法、包含化合物I的组合物以及使用式I化合物的方法。
• Effects of chronic mild stress on rats selectively bred for behavior related to bipolar disorder and depression
  作者：Ryan Murray、Katherine A. Boss-Williams、Jay M. Weiss

  DOI：10.1016/j.physbeh.2013.05.042

  日期：2013.7

  To test the possibility that chronic mild stress (CMS) might be unreliable in producing its often-intended outcome (i.e., decreased preference for sucrose, hypothesized to represent depression-relevant anhedonia) because it is typically applied to "normal" rats, a CMS procedure was applied to rats that may possess genetic susceptibility to affective disorders, having had been selectively-bred to show behavior indicative of such disorders. These rat lines were: Hyperactive (HYPER) rats, which show characteristics of bipolar disorder, Swim-test Susceptible (SUS) and Swim-test Resistant (RES) rats, being susceptible or resistant to effects of stress in the swim test, Swim High-active (SwHi) and Swim Low-active (SwLo) rats, which innately show high or low activity in the swim test These selectively-bred lines were compared to normal, non-selectively bred (NS) rats. During CMS, HYPER rats, both females and males, as well as RES and SwHi rats, showed reduced consumption of a palatable 2% sucrose solution, and reduced preference for sucrose (vs. water) in comparison to non-stressed rats (no CMS) of the same lines. In contrast, CMS produced no decrease in sucrose consumption or in preference for sucrose in normal NS rats, and actually a caused a slight increase in sucrose consumption and preference in male NS rats. Other measures that indicate depression - food intake and motor activity in the home cage - were also assessed. SwLo and SwHi showed greater sensitivity to having their home-cage ambulatory activity reduced by CMS than did NS rats, but no other such differences relative to NS rats were seen for these other measures; thus, changes in sucrose intake or preference could not be explained by a change in caloric intake. These results suggest that the genetic attributes of animals can influence the outcome of CMS, and that the application of CMS to normal, non-selected rats may account, at least in part, for the unreliability of CMS in decreasing consumption of palatable substances and decreasing preference for such substances. (C) 2013 Published by Elsevier Inc.